Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatasePaul Harmatz, Celeste Decker, Ida Vanessa Döederlein Schwartz et al.|Molecular Genetics and Metabolism|2008Cited by 216